News/Events: Press Releases

Select the news release you would like to view:

11-02-10		MiCardia Corporation Receives CE Mark Clearance to Market enCor™ Dynamic Mitral Valve Repair System in the European Union
10-01-10		MiCardia Corporation Announces Their Participation in a Scientific Session at the 25th Annual EACTS (European Association of Cardio-Thoracic Surgeons) Meeting in Geneva
10-26-2010		MiCardia Corporation Appoints Dr. Maurice Buchbinder as Chief Medical Officer
10-01-09		MiCardia® Announces Issuance of Ninth US Patent in Structural Heart Disease — "Shape Memory Devices and Methods for Reshaping Heart Anatomy"
09-04-09		MiCardia® Announces Completion of Enrollment in "DYANA" European CE Study
06-16-09		MiCardia® Announces First U.S. Implant
02-17-09		MiCardia® Announces Worlds' First Dynamic Heart Valve Repair on a Beating Heart
12-16-08		MiCardia® Announces First Patients Implanted
09-09-08		Micardia® Receives FDA Market Clearance
04-03-08		MiCardia® Receives Two New US Patents
09-21-06		Micardia® Completes $9 Million Private Financing

Caution: The enCor Mitral Valve Repair System is presently not available for sale in the US.

MiCardia, the MiCardia logo, enCor and enCor Mitral Valve Repair System are trademarks of MiCardia Corporation, registered in the United States.

AD4-0003 REV01 DC0271